金山科研平台，产品价格货期咨询微信：jinshanbio Source:Mouse myeloma cell line, NS0-derived Accession #:AAH19482 N-terminal Sequence Analysis:Ala27 Structure:Disulfide-linked homodimer Purity:>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. Predicted Molecular Mass:37.6 kDa (monomer) SDS-PAGE:50-60 kDa, reducing conditions Activity:Measured by its ability to bind Recombinant Mouse PILR‑alpha (Catalog# 4318-PR) in a functional ELISA. Shiratori, I. et al. (2004) J. Exp. Med. 199:525.Immobilized rhMSP beta chain at 5 µg/mL (100 µL/well) can bind rhMSP R with a linear range of 2.34 - 150 ng/mL. Formulation:Supplied as a 0.2 µm filtered solution in PBS.See Certificate of Analysis for details. Molecule Information: CD99 Aliases: CD99; MIC2; pilr-1; PILR-L Entrez Gene IDs: 4267 (Human); 673094 (Mouse); 652929 (Rat) Background: CD99 & CD99-L2 CD99 (also called PILR-L) and its family member, CD99 antigen-like 2 (CD99-L2) are type I transmembrane glycoproteins. CD99 and CD99-L2 share three conserved acidic motifs, show nearly ubiquitous expression and are thought to originate from the same ancestral gene. Both are expression on vascular endothelial cells and leukocytes and are reported to mediate leukocyte extravasation to inflamed tissue in vivo. CD99 is a receptor for PILR-alpha and -beta, which are found on selected leukocytes.